The primary objective of this randomized clinical trial is to determine the efficacy and
safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle
ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin
and finasteride.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)